Pharma Explained
Features
“Invest in sustainable pharma today in preparation for tomorrow”
Markus Laubscher, head of pharma at Orbia Fluor & Energy Materials discusses how in the pharmaceutical industry, the stakes are higher than most. Read more
The rise of decentralised science
Philipp Koellinger, CEO and co-founder of open science pioneer DeSci Labs, explains the reshaping of the scientific publishing landscape and explores what it means for scientists worldwide. Read more
Meaningful Integration: Building culture and success in pharma M&A
After the pharmaceutical industry’s muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025. Read more
Optimised R&D processes are paramount to keep pace with the market
Without aligned process improvements across Regulatory Affairs, Quality and Pharmacovigilance/Drug Safety, pharma companies risk limiting their overall market performance, says MAIN5’s Tobias Hitziger. Read more
Leaders in Pharma: Thermo Fisher Scientific
In the latest episode of MedTalk, we delve into the journey of leadership in the pharmaceutical industry with Urmi Prasad Richardson, President of EMEA at Thermo Fisher Scientific. Read more